0000950103-20-015724.txt : 20200812
0000950103-20-015724.hdr.sgml : 20200812
20200812210609
ACCESSION NUMBER: 0000950103-20-015724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC
CENTRAL INDEX KEY: 0001055951
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39430
FILM NUMBER: 201096854
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OrbiMed Capital GP IV LLC
CENTRAL INDEX KEY: 0001502240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39430
FILM NUMBER: 201096855
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orbimed ROF II LLC
CENTRAL INDEX KEY: 0001767936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39430
FILM NUMBER: 201096856
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVE., 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVE., 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acutus Medical, Inc.
CENTRAL INDEX KEY: 0001522860
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 451306615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 442-232-6080
MAIL ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
dp134361_4-orbimed.xml
FORM 4
X0306
4
2020-08-10
0
0001522860
Acutus Medical, Inc.
AFIB
0001055951
ORBIMED ADVISORS LLC
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001502240
OrbiMed Capital GP IV LLC
601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001767936
Orbimed ROF II LLC
601 LEXINGTON AVE., 54TH FLOOR
NEW YORK
NY
10022
1
0
1
0
Common Stock
2020-08-10
4
P
0
373500
18
A
373500
I
See footnotes
Common Stock
2020-08-10
4
P
0
41500
18
A
41500
I
See footnotes
Common Stock
2020-08-10
4
C
0
3784240
0
A
4157740
I
See footnotes
Common Stock
2020-08-10
4
C
0
1278718
0
A
1320218
I
See footnotes
Series B Convertible Preferred Stock
0
2020-08-10
4
C
0
872302
0
D
Common Stock
872302
0
I
See footnotes
Series B Convertible Preferred Stock
0
2020-08-10
4
C
0
673123
0
D
Common Stock
673123
0
I
See footnotes
Series C Convertible Preferred Stock
0
2020-08-10
4
C
0
647582
0
D
Common Stock
647582
0
I
See footnotes
Series C Convertible Preferred Stock
0
2020-08-10
4
C
0
899985
0
D
Common Stock
899985
0
I
See footnotes
Series D Convertible Preferred Stock
0
2020-08-10
4
C
0
389116
0
D
Common Stock
389116
0
I
See footnotes
Series D Convertible Preferred Stock
0
2020-08-10
4
C
0
1202117
0
D
Common Stock
1202117
0
I
See footnotes
Series D Convertible Preferred Stock
0
2020-08-10
4
C
0
378733
0
D
Common Stock
378733
0
I
See footnotes
These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV. OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IV. By virtue of such relationships, GP IV and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI IV and as a result may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI IV.
These securities are held of record by OrbiMed Royalty Opportunities II, LP ("ORO II"). OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II. OrbiMed Advisors is the managing member of ROF II. By virtue of such relationships, ROF II and
OrbiMed Advisors may be deemed to have voting and investment power over the securities held by ORO II and as a result may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a
management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by ORO II.
Each of GP IV, ROF II, and OrbiMed Advisors disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated a representative, currently David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer's board of directors.
Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series D Convertible Preferred Stock is convertible into the Issuer's Common Stock on a one-for-one basis for no additional consideration and has no expiration date.
OrbiMed Advisors LLC, By: /s/ Douglas Coon, Chief Compliance Officer
2020-08-12
OrbiMed Capital GP IV LLC, By: /s/ Douglas Coon, Chief Compliance Officer
2020-08-12
OrbiMed ROF II LLC, By: /s/ Douglas Coon, Chief Compliance Officer
2020-08-12